Resveratrol: Antioxidant & Cellular Protection

Resveratrol is filed under "antioxidants," but the label is only half right — and the half that is right is not the half most people assume. As a direct free-radical scavenger resveratrol is fairly ordinary; its more interesting activity is indirect, switching on the cell's own antioxidant and anti-inflammatory defenses (the Nrf2 pathway) and quieting inflammatory signaling (NF-κB). This page explains those mechanisms plainly, then gives an honest accounting of where resveratrol comes from: red wine, grapes, peanuts, and berries contain it, but in amounts so small that the wine-as-medicine idea collapses on arithmetic — which is exactly why every real supplement is extracted not from grapes but from the root of Japanese knotweed. It closes with the pharmacokinetics that constrain all of the above, and with safety.

Table of Contents

  1. What Resveratrol Is
  2. Direct Antioxidant Activity (Modest)
  3. Indirect Antioxidant Defense: Nrf2
  4. Anti-Inflammatory Mechanisms: NF-κB
  5. Hormesis and the Xenohormesis Idea
  6. Dietary Sources — and the Wine Arithmetic
  7. Supplements: Trans-Resveratrol and Knotweed
  8. The Bioavailability Problem in Detail
  9. Honest Bottom Line
  10. Safety, Tolerability & Interactions
  11. Key Research Papers
  12. Connections
  13. Featured Videos

What Resveratrol Is

Resveratrol is a stilbenoid — a small polyphenol built on a two-ring stilbene skeleton with three hydroxyl (–OH) groups, formally 3,5,4'-trihydroxy-trans-stilbene. Plants make it as a phytoalexin, a chemical shield deployed against fungal infection, ultraviolet radiation, and injury. It exists in two geometric forms: the biologically important trans isomer (what supplements and studies use) and a less-active cis isomer; light and heat can convert trans to cis, which is why quality supplements are protected from light. In plants much of it is stored as a glucoside called piceid (resveratrol with a sugar attached), which the body must cleave before absorption. Those hydroxyl groups let resveratrol donate electrons — the basis of its antioxidant chemistry — and also let it interact with numerous enzymes and receptors, which is why its biology is so sprawling.

Back to Table of Contents

Direct Antioxidant Activity (Modest)

As a direct scavenger of reactive oxygen species, resveratrol is real but unremarkable. In test-tube assays it neutralizes radicals and can chelate metal ions that catalyze oxidative damage, but on a molecule-for-molecule basis it is not a standout compared with vitamin C, vitamin E, or glutathione. More importantly, the very low tissue concentrations achieved after oral dosing mean that direct radical scavenging by intact resveratrol is unlikely to be its main mechanism in a living human — there simply is not enough free resveratrol circulating to mop up a meaningful share of the body's radical load. This is a crucial honesty point: the popular image of resveratrol as a powerful direct antioxidant flooding the bloodstream is not well supported. The action that matters is indirect.

Back to Table of Contents

Indirect Antioxidant Defense: Nrf2

The more compelling antioxidant story is that resveratrol acts as a mild stressor that switches on the cell's own defenses. The key node is Nrf2 (nuclear factor erythroid 2–related factor 2), a transcription factor that, when activated, moves into the nucleus and turns on a battery of protective genes through the antioxidant response element (ARE). These genes encode the endogenous antioxidant enzymes that do the real heavy lifting: superoxide dismutase (SOD), catalase, glutathione peroxidase, glutathione S-transferases, NAD(P)H quinone oxidoreductase, and heme oxygenase-1.

By nudging Nrf2, a small amount of resveratrol can produce an antioxidant effect far larger than its own scavenging capacity, because it recruits the cell's enzymatic machinery — catalytic systems that neutralize radicals continuously rather than one-for-one. This "turn on the factory rather than mop the floor yourself" mechanism is shared by many dietary polyphenols (see sulforaphane, one of the most potent Nrf2 activators) and is the most scientifically defensible sense in which resveratrol is an antioxidant. It also connects to the body's master antioxidant, glutathione, whose synthesis and recycling Nrf2 supports.

Back to Table of Contents

Anti-Inflammatory Mechanisms: NF-κB

Oxidative stress and inflammation are intertwined, and resveratrol's anti-inflammatory action is arguably better supported than its antioxidant one. Its central target is NF-κB (nuclear factor kappa-B), the master switch for inflammatory gene expression. Resveratrol inhibits NF-κB activation (partly through SIRT1-mediated deacetylation of its p65 subunit), reducing the transcription of pro-inflammatory cytokines (TNF-α, IL-6, IL-1β), adhesion molecules, and the enzymes COX-2 and iNOS. It also modulates other inflammatory pathways such as the NLRP3 inflammasome.

Because chronic low-grade inflammation underlies so many age-related diseases — atherosclerosis, insulin resistance, neurodegeneration — this anti-inflammatory activity is the thread that plausibly ties together the modest signals seen on the cardiovascular and metabolic pages (recall the reduced inflammatory markers in the Tomé-Carneiro coronary trials). As always, it is demonstrated mostly on biomarkers, and its real-world magnitude is limited by how little active resveratrol reaches tissue.

Back to Table of Contents

Hormesis and the Xenohormesis Idea

A unifying framework for all of the above is hormesis: the principle that a small dose of a stressor triggers an adaptive, protective response that leaves the organism more resilient. Resveratrol is not primarily a nutrient; it is a plant defense chemical, and in small amounts it appears to act on animals as a mild stressor that switches on stress-response programs (Nrf2, sirtuins, AMPK, autophagy).

David Sinclair and Konrad Howitz proposed the related idea of xenohormesis — that animals evolved to sense stress molecules produced by plants under duress (like resveratrol from a fungus-stressed grapevine) as an early-warning signal of deteriorating environmental conditions, pre-emptively activating their own protective pathways. It is an elegant hypothesis and a useful mental model, but it remains a hypothesis, not established fact, and it is sometimes invoked to lend resveratrol more certainty than the human data warrant. Hormesis also implies a dose ceiling: more is not better, and very high doses can flip from protective to harmful.

Back to Table of Contents

Dietary Sources — and the Wine Arithmetic

Resveratrol occurs in a handful of foods, almost always in small amounts:

The honest takeaway: no diet delivers a pharmacologically active resveratrol dose. Eating grapes, berries, and peanuts is worthwhile for many reasons — fiber, other polyphenols, vitamins — but not as a resveratrol delivery system. If resveratrol does anything meaningful, it does so only at supplement doses.

Back to Table of Contents

Supplements: Trans-Resveratrol and Knotweed

Commercial resveratrol is extracted from Japanese knotweed and standardized to a percentage of trans-resveratrol (look for that specific term, not just "resveratrol"). Typical supplement doses range from about 100 to 500 mg per day, with some longevity enthusiasts taking more; research doses have gone as high as 1–5 grams in short pharmacokinetic and cancer-chemoprevention studies. Formulation matters more than the label number because of the bioavailability problem below: micronized resveratrol, or resveratrol taken with a fat-containing meal or with piperine (black-pepper extract, which slows its glucuronidation), can raise blood levels relative to a plain-powder capsule. Quality varies widely, and third-party testing is worth seeking, because the supplement market is poorly policed and some products under-deliver on their stated content.

Back to Table of Contents

The Bioavailability Problem in Detail

This is the single most important fact about resveratrol as a supplement, and it deserves a full accounting. Walle and colleagues (Drug Metabolism and Disposition 2004) traced a labeled oral dose and found that resveratrol is well absorbed from the gut — about 70% crosses the intestinal wall — but that its oral bioavailability as free resveratrol is nearly zero, because the intestine and liver almost instantly conjugate it into resveratrol glucuronides and sulfates. Peak plasma concentrations of unchanged resveratrol are very low and short-lived; the conjugates dominate. Boocock and colleagues (2007) confirmed that even doses up to 5 grams produce only micromolar-and-below peaks of free resveratrol, and high doses can cause gastrointestinal side effects.

Two caveats keep the door open a crack. First, the glucuronide and sulfate metabolites are not necessarily inert — some may be transported into tissues and cleaved back to free resveratrol locally, acting as a slow-release reservoir. Second, the gut itself is exposed to high resveratrol concentrations before absorption, which is why the most plausible direct effects may be in the gastrointestinal tract. But the overarching reality stands: the tens-of-micromolar concentrations that produce dramatic effects in a petri dish are far above what oral resveratrol achieves in human tissue, and any honest reading of resveratrol's benefits must live inside that ceiling. It is the thread connecting the disappointments on every other page.

Back to Table of Contents

Honest Bottom Line

Back to Table of Contents

Safety, Tolerability & Interactions

Back to Table of Contents

Key Research Papers

  1. Walle T, Hsieh F, DeLegge MH, Oatis JE, Walle UK (2004). High absorption but very low bioavailability of oral resveratrol in humans. Drug Metabolism and Disposition, 32(12), 1377–1382. — PubMed 15333514
  2. Boocock DJ, et al. (2007). Phase I dose escalation pharmacokinetic study of resveratrol in healthy volunteers. Cancer Epidemiology, Biomarkers & Prevention, 16(6), 1246–1252. — PubMed 17548692
  3. Renaud S, de Lorgeril M (1992). Wine, alcohol, platelets, and the French paradox for coronary heart disease. The Lancet, 339(8808), 1523–1526. — PubMed 1351198
  4. Howitz KT, Sinclair DA, et al. (2003). Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan. Nature, 425(6954), 191–196. — PubMed 12939617
  5. Kaeberlein M, et al. (2005). Substrate-specific activation of sirtuins by resveratrol. Journal of Biological Chemistry, 280(17), 17038–17045. — PubMed 15684413
  6. Semba RD, et al. (2014). Resveratrol levels and all-cause mortality in older community-dwelling adults. JAMA Internal Medicine, 174(7), 1077–1084. — PubMed 24819981

PubMed Topic Searches

  1. PubMed: resveratrol & Nrf2
  2. PubMed: resveratrol & NF-κB
  3. PubMed: xenohormesis
  4. PubMed: dietary resveratrol content
  5. PubMed: improving resveratrol bioavailability

Back to Table of Contents

Connections

Back to Table of Contents